Pharmacology News and Research

Latest Pharmacology News and Research

Researchers identify molecule to fight myotubular myopathy

Myotubular myopathy is a severe genetic disease that leads to muscle paralysis from birth and results in death before two years of age. Although no treatment currently exists, researchers from the University of Geneva, Switzerland, - working in collaboration with the University of Strasbourg, France, - have identified a molecule that not only greatly reduces the progression of the disease but also boosts life expectancy in animal models by a factor of seven.

19 Nov 2018

New method studies how newborn baby's brain responds to being touched on face

A newborn baby's brain responds to being touched on the face, according to new research co-led by UCL.

19 Nov 2018

Game-Changers in Western Blotting and Protein Analysis

An interview with Ramya Prabakaran & Melody Chang from GenScript, discussing the development of automated systems that improve outcomes for western blotting.

From GenScript 16 Nov 2018

New pharmacological agent shows promise for prevention of heart rhythm disorders

A new pharmacological agent demonstrates promising results for the prevention of a wide range of heart rhythm disorders, including both cardiac and brain injury-induced arrhythmias.

15 Nov 2018

Researchers discover molecular basis for therapeutic actions of an African folk medicine

Researchers in the Department of Physiology & Biophysics at the University of California, Irvine School of Medicine have discovered the molecular basis for therapeutic actions of an African folk medicine used to treat a variety of illnesses and disorders including diabetes, pain, headaches, paralysis and epilepsy.

15 Nov 2018

NIH awards $3.4 million to UC researchers to study gastrointestinal lymphatic system

A team of researchers at the University of Cincinnati College of Medicine have been awarded $3.4 million by the National Institutes of Health to study the role of the gastrointestinal lymphatic system in dietary nutrient absorption and the transport of signaling molecules.

15 Nov 2018

GW study examines impact of nervous system on non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease, the accumulation of fat in the liver of people who drink little or no alcohol, affects 1 in 3 Americans. NAFLD is a significant risk factor for Type 2 diabetes, insulin resistance, and hepatic carcinoma, and incidence of the disease is increasing with the growing obesity epidemic in the United States.

8 Nov 2018

Study could provide novel treatment strategy for potentially blinding problem

An enzyme known to help our liver get rid of ammonia also appears to be good at protecting our retina, scientists report.

8 Nov 2018

Prostate cancer patients receiving androgen deprivation therapy may have higher heart failure risk

Androgen deprivation therapy was associated with a 72 percent higher risk of heart failure in a study of patients with prostate cancer.

7 Nov 2018

Study highlights need for interventions to improve statin use among older adults

In a British Journal of Clinical Pharmacology study of older adults prescribed statins, first-year nonadherence and discontinuation rates were high.

7 Nov 2018

Study examines timing of musculoskeletal adverse events that develop during statin therapy

Statins have been linked with muscle pain and other musculoskeletal adverse events in some patients. A new Pharmacology Research & Perspectives study has examined the timing of MAEs that develop during statin therapy and determined whether concomitant drugs used concurrently with statin therapy shifts the timing of MAEs.

7 Nov 2018

Researchers develop new device that improves balance in veterans with Gulf War illness

Gulf War veterans with unexplained illnesses that cause fatigue, headaches, respiratory disorders and memory problems can improve their balance with a device developed by Rutgers University researchers.

5 Nov 2018

Researchers find a class of drug that could be promising treatment for uveitis

Ocular inflammation uveitis is a serious disease that can destroy eye tissue and cause irreversible blindness.

2 Nov 2018

UA professor wins NIH grant to advance research in preventing heart failure

A University of Arizona College of Medicine - Phoenix researcher has received a $393,493 grant from the National Institutes of Health to further her research in reducing the risk of heart failure in patients with high blood pressure.

1 Nov 2018

New drug discovery will increase safety of canine sedation and anesthesia

A drug discovery made at the University of Helsinki's Faculty of Veterinary Medicine will increase the safety of animal sedation and anesthesia. Vatinoxan, the pharmacological molecule discovered in the study, reduced the adverse effects of other drugs on the cardiovascular system of canine patients.

31 Oct 2018

UA pharmacology professors aim to avoid opioid analgesic tolerance

For thousands of Americans, opioids no longer relieve pain -- they cause pain. Known as "opioid tolerance," patients eventually become desensitized to opioids and more sensitive to pain after years of using the pain relievers.

31 Oct 2018

New Penn Medicine Center offers hope in the fight against glioblastoma

Today, Penn Medicine is announcing the newest Translational Center of Excellence in the Abramson Cancer Center, focused on Glioblastoma Multiforme, the most common and lethal form of brain cancer.

30 Oct 2018

Natural protein may offer novel therapy to reverse disorders associated with metabolic syndrome

To the great surprise of cancer researchers, a protein they investigated for its possible role in cancer turned out to be a powerful regulator of metabolism.

29 Oct 2018

Bioengineering scientists propose new paradigm for research into cardiovascular diseases

Thrombosis-on-a-chip, vasculature-on-a-chip and engineered models of human cardiac fibrosis are just a few of the new technologies revolutionizing research into human cardiovascular disease--a condition responsible for 17 million deaths per annum globally.

25 Oct 2018

Scientists engineer antiviral peptide that exploits Achilles' heel of Zika virus

Scientists at Nanyang Technological University, Singapore have engineered an antiviral peptide that exploits the Zika virus at its Achilles' heel - the viral membrane - hence stopping the virus from causing severe infections.

24 Oct 2018

Pharmacology News and Research

Latest Pharmacology News and Research

Researchers identify molecule to fight myotubular myopathy

New method studies how newborn baby's brain responds to being touched on face

Game-Changers in Western Blotting and Protein Analysis

New pharmacological agent shows promise for prevention of heart rhythm disorders

Researchers discover molecular basis for therapeutic actions of an African folk medicine

NIH awards $3.4 million to UC researchers to study gastrointestinal lymphatic system

GW study examines impact of nervous system on non-alcoholic fatty liver disease

Study could provide novel treatment strategy for potentially blinding problem

Prostate cancer patients receiving androgen deprivation therapy may have higher heart failure risk

Study highlights need for interventions to improve statin use among older adults

Study examines timing of musculoskeletal adverse events that develop during statin therapy

Researchers develop new device that improves balance in veterans with Gulf War illness

Researchers find a class of drug that could be promising treatment for uveitis

UA professor wins NIH grant to advance research in preventing heart failure

New drug discovery will increase safety of canine sedation and anesthesia

UA pharmacology professors aim to avoid opioid analgesic tolerance

New Penn Medicine Center offers hope in the fight against glioblastoma

Natural protein may offer novel therapy to reverse disorders associated with metabolic syndrome

Bioengineering scientists propose new paradigm for research into cardiovascular diseases

Scientists engineer antiviral peptide that exploits Achilles' heel of Zika virus

Industry Focus - Biopharma eBook

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Pharmacology News and Research

Latest Pharmacology News and Research

Industry Focus - Biopharma eBook

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Newsletters you may be interested in